{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:00:47Z","timestamp":1791918047271,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-00265442"],"award-info":[{"award-number":["RS-2023-00265442"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection primarily affects the respiratory system but may induce hematological alterations such as anemia, lymphopenia and thrombocytopenia. Previous studies have reported that SARS-CoV-2 efficiently infects hematopoietic stem and progenitor cells (HSPCs); however, the subsequent effects on hematopoiesis and immune reconstitution have not yet been described. Here we evaluated the pathological effects of infection of umbilical-cord-blood-derived HSPCs with the SARS-CoV-2 Omicron variant pseudovirus (PsV). Transcriptomic analysis of Omicron PsV-infected HSPCs revealed the upregulation of genes involved in inflammation, aging and the NLRP3 inflammasome, suggesting a potential trigger of inflammaging. Omicron PsV-infected HSPCs presented decreased numbers of multipotential progenitors (granulocyte\u2012erythrocyte\u2012macrophage\u2012megakaryocyte colony-forming units) ex vivo and repopulated primitive hematopoietic stem cells (Ki-67<jats:sup>\u2212<\/jats:sup>hCD34<jats:sup>+<\/jats:sup> cells) in an HSPC transplantation NOD-scid IL2r\u03b3<jats:sup>null<\/jats:sup> mouse model (Omicron mouse). Furthermore, Omicron PsV infection induced myeloid-biased differentiation of HSPCs. Treatment with nanographene oxide, an antiviral agent, partially mitigated the myeloid bias and inflammaging phenotype both in vitro and in vivo. These findings provide insights into the abnormal hematopoietic and immune effects of SARS-CoV-2 infection and highlight potential therapeutic interventions.<\/jats:p>","DOI":"10.1038\/s12276-025-01416-1","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T01:01:42Z","timestamp":1740963702000},"page":"616-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["SARS-CoV-2 pseudovirus dysregulates hematopoiesis and induces inflammaging of hematopoietic stem and progenitor cells"],"prefix":"10.1038","volume":"57","author":[{"given":"Dong-Hoon","family":"Chae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-2161","authenticated-orcid":false,"given":"Kyoung-Myeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Han","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Kyung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaechul","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia E.","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-2137","authenticated-orcid":false,"given":"Hee Min","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Rok","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"1416_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Liu, Q. & Guo, D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92, 418\u2013423 (2020).","journal-title":"J. Med. Virol."},{"key":"1416_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"1416_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu, B., Guo, H., Zhou, P. & Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141\u2013154 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1416_CR4","doi-asserted-by":"publisher","first-page":"e105114","DOI":"10.15252\/embj.20105114","volume":"39","author":"S Lukassen","year":"2020","unstructured":"Lukassen, S. et al. SARS\u2010CoV\u20102 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells. EMBO J. 39, e105114 (2020).","journal-title":"EMBO J."},{"key":"1416_CR5","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.3390\/jcm11164896","volume":"11","author":"J Selickman","year":"2022","unstructured":"Selickman, J., Vrettou, C. S., Mentzelopoulos, S. D. & Marini, J. J. COVID-19-related ARDS: key mechanistic features and treatments. J. Clin. Med. 11, 4896 (2022).","journal-title":"J. Clin. Med."},{"key":"1416_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"1416_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269\u2013270 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1416_CR8","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","volume":"34","author":"MZ Ratajczak","year":"2020","unstructured":"Ratajczak, M. Z. & Kucia, M. SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \u201cstorm\u201d and risk factor for damage of hematopoietic stem cells. Leukemia 34, 1726\u20131729 (2020).","journal-title":"Leukemia"},{"key":"1416_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"1416_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ijid.2020.12.078","volume":"103","author":"J Ihlow","year":"2021","unstructured":"Ihlow, J. et al. B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased. Int. J. Infect. Dis. 103, 628\u2013635 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"1416_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00018-022-04220-6","volume":"79","author":"S Elahi","year":"2022","unstructured":"Elahi, S. Hematopoietic responses to SARS-CoV-2 infection. Cell. Mol. Life Sci. 79, 187 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"1416_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ajcp\/aqaa274","volume":"155","author":"CK Harris","year":"2021","unstructured":"Harris, C. K., Hung, Y. P., Nielsen, G. P., Stone, J. R. & Ferry, J. A. Bone marrow and peripheral blood findings in patients infected by SARS-CoV-2. Am. J. Clin. Pathol. 155, 627\u2013637 (2021).","journal-title":"Am. J. Clin. Pathol."},{"key":"1416_CR13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/microorganisms9081632","volume":"9","author":"MG Balzanelli","year":"2021","unstructured":"Balzanelli, M. G. et al. SARS-CoV-2 virus infection may interfere CD34+ hematopoietic stem cells and megakaryocyte\u2013erythroid progenitors differentiation contributing to platelet defection towards insurgence of thrombocytopenia and thrombophilia. Microorganisms 9, 1632 (2021).","journal-title":"Microorganisms"},{"key":"1416_CR14","first-page":"11","volume":"9","author":"Z Li","year":"2023","unstructured":"Li, Z., Lee, J.-E., Cho, N. & Yoo, H. M. Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses. Heliyon 9, 11 (2023).","journal-title":"Heliyon"},{"key":"1416_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12929-021-00729-3","volume":"28","author":"S-H Tseng","year":"2021","unstructured":"Tseng, S.-H. et al. A novel pseudovirus\u2010based mouse model of SARS-CoV-2 infection to test COVID-19 interventions. J. Biomed. Sci. 28, 34 (2021).","journal-title":"J. Biomed. Sci."},{"key":"1416_CR16","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.apsb.2021.09.004","volume":"12","author":"C Wu","year":"2022","unstructured":"Wu, C. et al. Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles. Acta Pharm. Sin. B 12, 1523\u20131533 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"1416_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jconrel.2021.05.049","volume":"335","author":"Y Fu","year":"2021","unstructured":"Fu, Y. & Xiong, S. Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection. J. Control. Release 335, 584\u2013595 (2021).","journal-title":"J. Control. Release"},{"key":"1416_CR18","doi-asserted-by":"crossref","unstructured":"Ikemura, N. et al. An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo. Sci. Transl. Med. 14, eabn7737.","DOI":"10.1126\/scitranslmed.abn7737"},{"key":"1416_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40824-023-00357-y","volume":"27","author":"J-E Lee","year":"2022","unstructured":"Lee, J.-E. et al. Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models. Biomater. Res. 27, 18 (2022).","journal-title":"Biomater. Res."},{"key":"1416_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1021\/tx200339h","volume":"25","author":"VC Sanchez","year":"2012","unstructured":"Sanchez, V. C., Jachak, A., Hurt, R. H. & Kane, A. B. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem. Res. Toxicol. 25, 15\u201334 (2012).","journal-title":"Chem. Res. Toxicol."},{"key":"1416_CR21","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.3390\/ma14154250","volume":"14","author":"S Jaworski","year":"2021","unstructured":"Jaworski, S. et al. Comparison of the toxicity of pristine graphene and graphene oxide, using four biological models. Materials 14, 4250 (2021).","journal-title":"Materials"},{"key":"1416_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/ijms20020247","volume":"20","author":"S Gurunathan","year":"2019","unstructured":"Gurunathan, S., Kang, M.-H., Jeyaraj, M. & Kim, J.-H. Differential immunomodulatory effect of graphene oxide and vanillin-functionalized graphene oxide nanoparticles in human acute monocytic leukemia cell line (THP-1). Int. J. Mol. Sci. 20, 247 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1416_CR23","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1021\/acsnano.7b09107","volume":"12","author":"J Han","year":"2018","unstructured":"Han, J. et al. Dual roles of graphene oxide to attenuate inflammation and elicit timely polarization of macrophage phenotypes for cardiac repair. ACS Nano 12, 1959\u20131977 (2018).","journal-title":"ACS Nano"},{"key":"1416_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100062","volume":"2","author":"A Rhazouani","year":"2021","unstructured":"Rhazouani, A. et al. Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention. Curr. Res. Pharmacol. Drug Discov. 2, 100062 (2021).","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"1416_CR25","doi-asserted-by":"publisher","first-page":"1032899","DOI":"10.3389\/fmed.2022.1032899","volume":"9","author":"Er,S Gungordu","year":"2022","unstructured":"Gungordu, Er, S., Tabish, T. A., Edirisinghe, M. & Matharu, R. K. Antiviral properties of porous graphene, graphene oxide and graphene foam ultrafine fibers against Phi6 bacteriophage. Front. Med 9, 1032899 (2022).","journal-title":"Front. Med"},{"key":"1416_CR26","doi-asserted-by":"publisher","first-page":"21571","DOI":"10.1021\/acsami.5b06876","volume":"7","author":"S Ye","year":"2015","unstructured":"Ye, S. et al. Antiviral activity of graphene oxide: how sharp edged structure and charge matter. ACS Appl. Mater. Interf. 7, 21571\u201321579 (2015).","journal-title":"ACS Appl. Mater. Interf."},{"key":"1416_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2021.100099","volume":"11","author":"T Seifi","year":"2021","unstructured":"Seifi, T. & Kamali, A. R. Antiviral performance of graphene-based materials with emphasis on COVID-19: a review. Med. Drug Discov. 11, 100099 (2021).","journal-title":"Med. Drug Discov."},{"key":"1416_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.15283\/ijsc21178","volume":"15","author":"HS Park","year":"2022","unstructured":"Park, H. S. et al. Diesel exhaust particles impair therapeutic effect of human Wharton\u2019s jelly-derived mesenchymal stem cells against experimental colitis through ROS\/ERK\/cFos signaling pathway. Int. J. Stem Cells 15, 203\u2013216 (2022).","journal-title":"Int. J. Stem Cells"},{"key":"1416_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1182\/blood-2017-06-746412","volume":"131","author":"G de Haan","year":"2018","unstructured":"de Haan, G. & Lazare, S. S. Aging of hematopoietic stem cells. Blood 131, 479\u2013487 (2018).","journal-title":"Blood"},{"key":"1416_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fimmu.2016.00502","volume":"7","author":"LV Kovtonyuk","year":"2016","unstructured":"Kovtonyuk, L. V., Fritsch, K., Feng, X., Manz, M. G. & Takizawa, H. Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment. Front. Immunol. 7, 502 (2016).","journal-title":"Front. Immunol."},{"key":"1416_CR31","doi-asserted-by":"publisher","first-page":"e1000215","DOI":"10.1371\/journal.ppat.1000215","volume":"4","author":"A Alexaki","year":"2008","unstructured":"Alexaki, A. & Wigdahl, B. HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog. 4, e1000215 (2008).","journal-title":"PLoS Pathog."},{"key":"1416_CR32","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1182\/blood.V92.9.3328","volume":"92","author":"D Sansonno","year":"1998","unstructured":"Sansonno, D. et al. Hepatitis C virus infection involves CD34+ hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 92, 3328\u20133337 (1998).","journal-title":"Blood"},{"key":"1416_CR33","unstructured":"Wang, F.-Z. & Pellett, P. E. HHV-6A, 6B, and 7: immunobiology and host response. In: Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., & Yamanishi, K. editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; Chapter 48 (2007)."},{"key":"1416_CR34","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/eji.200737112","volume":"37","author":"M Sioud","year":"2007","unstructured":"Sioud, M. & Fl\u00f8isand, Y. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80\/86+ DC capable of inducing a Th1\u2010type response. Eur. J. Immunol. 37, 2834\u20132846 (2007).","journal-title":"Eur. J. Immunol."},{"key":"1416_CR35","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jmb.2006.09.054","volume":"364","author":"M Sioud","year":"2006","unstructured":"Sioud, M., Fl\u00f8isand, Y., Forfang, L. & Lund-Johansen, F. Signaling through toll-like receptor 7\/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. J. Mol. Biol. 364, 945\u2013954 (2006).","journal-title":"J. Mol. Biol."},{"key":"1416_CR36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07815","volume":"458","author":"MAG Essers","year":"2009","unstructured":"Essers, M. A. G. et al. IFN\u03b1 activates dormant haematopoietic stem cells in vivo. Nature 458, 904\u2013908 (2009).","journal-title":"Nature"},{"key":"1416_CR37","volume":"71","author":"F Zeylabi","year":"2023","unstructured":"Zeylabi, F., Nameh Goshay Fard, N., Parsi, A. & Pezeshki, S. M. S. Bone marrow alterations in COVID-19 infection: the root of hematological problems. Curr. Res. Transl. Med. 71, 103407 (2023).","journal-title":"Curr. Res. Transl. Med."},{"key":"1416_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-021-03647-4","volume":"595","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature 595, 421\u2013425 (2021).","journal-title":"Nature"},{"key":"1416_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107567","volume":"95","author":"B Zheng","year":"2021","unstructured":"Zheng, B. et al. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues. Int. Immunopharmacol. 95, 107567 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"1416_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.exger.2006.11.019","volume":"42","author":"D Rossi","year":"2007","unstructured":"Rossi, D., Bryder, D. & Weissman, I. Hematopoietic stem cell aging: mechanism and consequence. Exp. Gerontol. 42, 385\u2013390 (2007).","journal-title":"Exp. Gerontol."},{"key":"1416_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-020-00864-8","volume":"13","author":"X Li","year":"2020","unstructured":"Li, X. et al. Mechanisms and rejuvenation strategies for aged hematopoietic stem cells. J. Hematol. Oncol. 13, 31 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"1416_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-021-00296-9","volume":"7","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Dysregulated hematopoiesis in bone marrow marks severe COVID-19. Cell Discov. 7, 60 (2021).","journal-title":"Cell Discov."},{"key":"1416_CR43","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-J Guan","year":"2020","unstructured":"Guan, W.-J. et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"New Engl. J. Med."},{"key":"1416_CR44","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.stemcr.2021.04.001","volume":"16","author":"S Shahbaz","year":"2021","unstructured":"Shahbaz, S. et al. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2. Stem Cell Rep. 16, 1165\u20131181 (2021).","journal-title":"Stem Cell Rep."},{"key":"1416_CR45","doi-asserted-by":"publisher","first-page":"e0173022","DOI":"10.1128\/spectrum.01730-22","volume":"10","author":"S Saito","year":"2022","unstructured":"Saito, S. et al. Differential Impact of SARS-CoV-2 Isolates, Namely, the Wuhan Strain, Delta, and Omicron Variants on Erythropoiesis. Microbiol. Spectr. 10, e0173022 (2022).","journal-title":"Microbiol. Spectr."},{"key":"1416_CR46","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.4049\/jimmunol.2300783","volume":"212","author":"S Saito","year":"2024","unstructured":"Saito, S., Bozorgmehr, N., Sligl, W., Osman, M. & Elahi, S. The role of coinhibitory receptors in B cell dysregulation in SARS-CoV-2\u2013infected individuals with severe disease. J. Immunol. 212, 1540\u20131552 (2024).","journal-title":"J. Immunol."},{"key":"1416_CR47","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1002\/vms3.584","volume":"7","author":"HC Chung","year":"2021","unstructured":"Chung, H. C. et al. Application of nano\u2010graphene oxide as nontoxic disinfectant against alpha and betacoronaviruses. Vet. Med. Sci. 7, 2434\u20132439 (2021).","journal-title":"Vet. Med. Sci."},{"key":"1416_CR48","doi-asserted-by":"publisher","first-page":"102788","DOI":"10.1016\/j.isci.2021.102788","volume":"24","author":"F De Maio","year":"2021","unstructured":"De Maio, F. et al. Graphene nanoplatelet and graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-2. iScience 24, 102788 (2021).","journal-title":"iScience"},{"key":"1416_CR49","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.bbamem.2015.02.018","volume":"1848","author":"L Rui","year":"2015","unstructured":"Rui, L. et al. Reduced graphene oxide directed self-assembly of phospholipid monolayers in liquid and gel phases. Biochim. Biophys. Acta Biomembr. 1848, 1203\u20131211 (2015).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"1416_CR50","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/smll.201401706","volume":"11","author":"Z Song","year":"2015","unstructured":"Song, Z. et al. Virus capture and destruction by label\u2010free graphene oxide for detection and disinfection applications. Small 11, 1171\u20131176 (2015).","journal-title":"Small"},{"key":"1416_CR51","doi-asserted-by":"publisher","first-page":"11949","DOI":"10.1021\/acsnano.8b03642","volume":"12","author":"C Hoyle","year":"2018","unstructured":"Hoyle, C. et al. Small, thin graphene oxide is anti-inflammatory activating nuclear factor erythroid 2-related factor 2 via metabolic reprogramming. ACS Nano 12, 11949\u201311962 (2018).","journal-title":"ACS Nano"},{"key":"1416_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NSA.S391761","volume":"16","author":"J Balaban","year":"2023","unstructured":"Balaban, J. et al. Graphene oxide decreases pro-inflammatory proteins production in skeletal muscle cells exposed to SARS-CoV-2 spike protein. Nanotechnol. Sci. Appl. 16, 1\u201318 (2023).","journal-title":"Nanotechnol. Sci. Appl."},{"key":"1416_CR53","doi-asserted-by":"publisher","first-page":"15214","DOI":"10.1039\/C5NR01839K","volume":"7","author":"G Duan","year":"2015","unstructured":"Duan, G. et al. Protein corona mitigates the cytotoxicity of graphene oxide by reducing its physical interaction with cell membrane. Nanoscale 7, 15214\u201315224 (2015).","journal-title":"Nanoscale"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01416-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01416-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01416-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T02:58:59Z","timestamp":1743735539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01416-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01416-1","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}